Despite Slowing Disease Progression, Amgen's Lung Cancer Studies Show High Liver Toxicity

Press/Media

Period	Aug 8 2022

Media coverage

Title	Despite Slowing Disease Progression, Amgen's Lung Cancer Studies Show High Liver Toxicity
Media name/outlet	BioSpace
Country/Territory	United States
Date	08/8/22
URL	https://www.biospace.com/article/amgen-shares-progress-in-lumakras-combo-trial-for-nsclc-tarlatamab-in-sclc/
Persons	Hossein Borghaei